We know that generic drugs are designed to work the same way as name brand drugs, but for a lower price. An emerging group of medications called biosimilars are aiming to do the same thing for biologic drugs.
So, if biosimilars can reduce that cost, it could make a big difference in the lives of people dealing with things like cancer, multiple sclerosis, and rare diseases. "This is kind of why biosimilars have come to market. They cost on average, about 50% less than reference products or brand products, but some can cost up to 85% less."
Since biologic drugs are made from living organisms, it's impossible to replicate them exactly. But a very similar drug can be made, hence the name biosimilar.
Source: Education Headlines (educationheadlines.net)
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New York City, New York job with Columbia Center for Translational ImmunologyThe Laboratory of Arnold Han MD, PhD is inviting applications for a dynamic and highly motivated postdoctoral research scientist to join his research program in immunology at Columbia University Vagelos College of Physicians and Surgeons.
Source: Nature - 🏆 64. / 68 Read more »
Source: NewYorker - 🏆 90. / 67 Read more »
Source: fox5ny - 🏆 587. / 51 Read more »
Source: CBSNewYork - 🏆 268. / 63 Read more »
Source: WIRED - 🏆 555. / 51 Read more »
Source: CBSNewYork - 🏆 268. / 63 Read more »